Center-Authored Papers

Filters: Author is Jackson, J Brooks  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2010
Church JD, Huang W, Mwatha A, Musoke P, Jackson BJ, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C et al..  2010.  Analysis of HIV tropism in ugandan infants.. Current HIV research. 8(7):498-503. Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
2012
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou S-S et al..  2012.  Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa.. Journal of acquired immune deficiency syndromes (1999). Abstract
2013
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L et al..  2013.  Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Allen M, Jackson BJ, Fowler MG, Guay LA.  2013.  Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival.. Journal of acquired immune deficiency syndromes (1999). 64(5):464-71. Abstract
2014
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
Adult
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Buprenorphine
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Center-Authored Paper
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou S-S et al..  2012.  Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa.. Journal of acquired immune deficiency syndromes (1999). Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Church JD, Huang W, Mwatha A, Musoke P, Jackson BJ, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C et al..  2010.  Analysis of HIV tropism in ugandan infants.. Current HIV research. 8(7):498-503. Abstract
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
China
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
DNA, Viral
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Female
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Genetic Variation
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Genome, Viral
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
HIV
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
HIV Infections
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Humans
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Incidence
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract